Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease

Journal of Nuclear Medicine

Volumn 38, Issue 9, 1997, Pages 1463-1467

  Ohnishi, Takashi ^a   Yano, Takao ^b   Nakano, Shinichi ^b   Jinnouchi, Seishi ^b   Nagamachi, Shigeki ^b   Flores II, Leo ^b   Nakahara, Hiroshi ^b   Watanabe, Katsushi ^b  

^a Junwa Memorial Hospital   (Japan)

^b NONE

Author keywords

Acetazolamide challenge; Linearization correction; Technetium 99m ECD

Indexed keywords

ACETAZOLAMIDE; CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IOFETAMINE I 123;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROVOCATION TEST; RESEARCH; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TECHNIQUE;

ACETAZOLAMIDE; AGED; AGED, 80 AND OVER; AMPHETAMINES; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; CHRONIC DISEASE; CYSTEINE; FEMALE; HUMANS; IOFETAMINE; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATION;

EID: 0030964558     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kung HF, Ohmomo Y, Kung MP. Current and future radiopharmaceuticals for brain imaging with single-photon emission computed tomography. Semin Nucl Med 1990; 20:290-302.
2. 99mTc bicisate as an agent for the measurement of cerebral blood flow with SPECT. J Cereb Blood Flow and Metabol 1994;14(suppl 1):S1-S3.
3. 99mTc bicisate in humans and in rats. J Cereb Blood Flow and Metabol 1994;14(suppl 1):S12-S18.
4. 99mTc bicisate: comparison with PET measurement and linearization based on permeability-surface area product model. J Cereb Blood Flow and Metabol 1994;14(suppl 1):S58-S65.
5. 99mTc bicisate in patients with cerebrovascular disease in comparison with CBF and CMRO2 measured by positron emission tomography. J Cereb Blood Flow and Metabol 1994;14(suppl 1):S66-S75.
6. 99mTc-ECD SPECT. J Cereb Blood Flow and Metabol 1994;14(suppl 1):S49-S57.
7. 99mTc bicisate in the human brain after intracarotid injection. J Cereb Blood Flow and Metabol 1994;14(suppl 1):S19-S27.
8. Vorstrup S. Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease, and evaluation of the vasodilatory capacity by the acetazolamide test. Acta Neurol Scand 1988;77:5-48.
9. Vorstrup S, Brun B, Lassen NA. Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery. Stroke 1986;17:1291-1298.
10. Hirano T, Minematsu K, Hasegawa Y, et al. Acetazolamide reactivity on I-123 IMP single-photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters. J Cereb Blood Flow Metabol 1994;14:763-770.
11. Yamashita T, Hayashi M, Kashiwagi S, et al. Cerebrovascular reserve capacity in ischemia due to occlusion of major arterial trunk: studies by Xe-CT and the acetazolamide test. J Comput Assist Tomogr 1992;16:750-755.
12. Moretti JL, Caglar M, Weinmann P. Cerebral perfusion imaging tracers for SPECT: which one to choose? J Nucl Med 1995;36:359-363.
13. 99mTc-ECD in nonhuman primates. J Nucl Med 1989;30:1892-1901.
14. 99mTc d, 1-HMPAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow and Metabol 1988;8:S13-S22.
15. 99mTc-labeled hexamethyl-propylene amine oxime (HMPAO) image in terms of regional CBF distribution: comparison to C15 O2 inhalation steady-state method measured by positron emission tomography. J Cereb Blood Flow and Metabol 1988;8:S52-S60.
16. 99mTc d,1-hexamethylpropylene amine oxime (HMPAO) compared with regional cerebral blood flow measured by PET: effects of linearization. J Cereb Blood Flow and Metabol 1988;8:S82-S89.
17. 99mTc-HMPAO in healthy human subjects. J Nucl Med 1992;33:1902-1910.
18. 99mTc-HMPAO [Abstract]. J Nucl Med 1992;33:909.
19. Kuhl DE, Barrio JR, Huang SC, et al. Quantifying local cerebral blood flow by N isopropyl p 123 iodoamphetamine (IMP) tomography. J Nucl Med 1982;23:196-203.
20. 123I-IMP SPECT: sequential quantitative regional cerebral blood flow change with pharmacological intervention. J Nucl Med 1994;35:1226-1233.
21. 99mTc bicisate in activation studies by split-dose technique. J Cereb Blood Flow and Metabol 1994;14(suppl 1):S115-S120.
22. 123I-IMP in subacute strokes. J Nucl Med 1994;35:1444-1449.